The proportion of Australians who have more than one liver disease is increasing, with unknown impacts on clinical severity and liver-related health outcomes.
In this study, we describe the prevalence and clinical impact of concurrent liver diseases among people undergoing liver transplantation for liver cirrhosis and liver cancer in Australia and New Zealand.
We aim to:
2020–2022.
This project is a longitudinal cohort study-analysis of the Australian and New Zealand Liver and Intestinal Transplant Registry data.
Understanding the impact of having more than one liver disease on liver-related outcomes and mortality is vital to inform clinical management of people with chronic liver disease.
Moreover, correctly attributing adverse liver outcomes to all contributing liver diseases when more than one is present is vital to guide proportionate investment and health policy development in liver disease prevention programs.
Australian and New Zealand Liver and Intestinal Transplant Consortium